June 19, 2013
Today, the U.S. Department of Health and Human Services (HHS) released a new guideline to improve patient safety by reducing unexpected disease transmission through organ transplantation. This guideline updates the 1994 U.S. Public Health Service (PHS) guideline for preventing transmission of human immunodeficiency virus (HIV) through organ transplantation and adds guidance for reducing unexpected transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) through organ transplants.
The 2013 PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus Transmission through Organ Transplantation, published in Public Health Reports, recommends the use of more sensitive tests so that patients can be informed of risks to the greatest extent possible and protected from unintentional infections caused by transplanted organs.
"Transmission of infections through organ transplants is a critical concern for patients, their families and healthcare personnel involved in transplant procedures," said HHS Assistant Secretary for Health Howard K. Koh, M.D., M.P.H. "Putting these new recommendations into practice will allow doctors and patients to make better, more informed decisions when accepting organs for transplantation."
To update standards for safe transplants, CDC led an HHS workgroup comprised of experts on evidence-based guidelines and a multidisciplinary group that included transplant and infection prevention experts to conduct a systematic review of the best available evidence on reducing HIV, HBV and HCV infection transmitted through organ transplantation. The 2013 PHS guideline includes recommendations based on this review.
The major changes from the previous PHS guideline are:
"The decision to accept the risk and the benefit of an organ transplant should be made by a fully informed patient, and the new guideline will help patients and their doctors have the information they need to weigh risks and benefits of transplanting a particular organ," said Matthew J. Kuehnert, M.D., director of CDC's Office of Blood, Organ, and Other Tissue Safety.
Several federal agencies oversee or regulate aspects of the procurement and transplantation of organs. The Health Resources and Services Administration (HRSA) provides oversight of solid organ transplantation, including donor screening policies, recipient evaluation and informed consent, through the Organ Procurement and Transplantation Network (OPTN), established by Congress under the National Organ Transplant Act of 1984. This act requires the OPTN to be administrated by a private, non-profit entity through a contract overseen by HRSA. The United Network for Organ Sharing is the entity that operates the OPTN. The Centers for Medicare and Medicaid Services (CMS) establishes performance standards and conducts surveys of transplant centers and organ procurement organizations (OPOs) to determine certification or recertification. Currently, there are 58 OPOs and 247 organ transplant centers in the United States. Public Health Reports is the official journal of the U.S. Public Health Service and the Office of the Surgeon General. It is published by the Association of Schools of Public Health.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade|
|CROI 2018: Highlights and What's Next for Advocates|
|Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence|
|Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives|
|Statin Use Might Reduce Risk of Cancer in HIV-Positive People|
|Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say|